An Open-label Study Assessing Safety, Immunogenicity and Dose Response of IC84

Clinical trial NCT01296386 · COMPLETED

Trial details

NCT number: NCT01296386
Sponsor: Valneva Austria GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Clostridium Difficile Infection

Start date: 2010-12-01
Primary completion: 2013-04-01
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.